CARE RATINGS
|
CARE RATINGS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 |
| CEPS(Rs) | 62.59 | 50.69 | 37.87 | 32.32 | 28.51 |
| DPS(Rs) | 22.00 | 18.00 | 18.00 | 25.00 | 17.00 |
| Book NAV/Share(Rs) | 308.68 | 267.56 | 238.52 | 224.16 | 215.75 |
| Tax Rate(%) | 26.20 | 27.18 | 30.05 | 32.04 | 22.10 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 41.73 | 38.61 | 33.81 | 35.61 | 32.15 |
| EBIT Margin(%) | 50.28 | 48.31 | 44.72 | 45.43 | 40.02 |
| Pre Tax Margin(%) | 49.75 | 47.79 | 44.21 | 45.07 | 39.83 |
| PAT Margin (%) | 36.72 | 34.80 | 30.92 | 30.63 | 31.03 |
| Cash Profit Margin (%) | 39.75 | 37.71 | 34.08 | 34.40 | 34.14 |
| Performance Ratios | |||||
| ROA(%) | 16.84 | 15.56 | 12.73 | 8.43 | 6.32 |
| ROE(%) | 20.10 | 18.51 | 14.89 | 13.09 | 12.76 |
| ROCE(%) | 27.36 | 25.52 | 21.35 | 19.21 | 16.03 |
| Asset Turnover(x) | 0.46 | 0.45 | 0.41 | 0.28 | 0.20 |
| Sales/Fixed Asset(x) | 2.73 | 2.55 | 2.34 | 2.22 | 2.29 |
| Working Capital/Sales(x) | 0.85 | 0.68 | 0.56 | 0.51 | 0.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.37 | 0.39 | 0.43 | 0.45 | 0.44 |
| Receivable days | 25.89 | 24.75 | 23.59 | 24.22 | 28.00 |
| Inventory Days | - | - | - | - | - |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 25.27 | 24.01 | 33.18 | 22.86 | 20.21 |
| PCE(x) | 23.00 | 21.72 | 29.50 | 19.89 | 17.96 |
| Price/Book(x) | 4.66 | 4.11 | 4.68 | 2.87 | 2.37 |
| Yield(%) | 1.53 | 1.64 | 1.61 | 3.89 | 3.32 |
| EV/Net Sales(x) | 8.87 | 7.95 | 9.88 | 6.64 | 5.80 |
| EV/Core EBITDA(x) | 16.64 | 15.52 | 20.63 | 13.50 | 13.45 |
| EV/EBIT(x) | 17.65 | 16.45 | 22.09 | 14.62 | 14.49 |
| EV/CE(x) | 4.50 | 3.97 | 4.57 | 2.76 | 1.14 |
| M Cap / Sales | 9.15 | 8.19 | 10.06 | 6.84 | 6.13 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 17.59 | 21.30 | 18.89 | 12.66 | -0.33 |
| Core EBITDA Growth(%) | 22.38 | 29.76 | 15.70 | 28.54 | -15.95 |
| EBIT Growth(%) | 22.36 | 31.03 | 17.04 | 27.91 | -16.91 |
| PAT Growth(%) | 24.07 | 36.50 | 20.02 | 11.23 | -15.54 |
| EPS Growth(%) | 24.25 | 36.16 | 19.74 | 11.01 | -16.62 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 5.76 | 7.08 | 8.57 | 10.41 | 1.88 |
| Quick Ratio(x) | 5.76 | 7.08 | 8.57 | 10.41 | 1.88 |
| Interest Cover(x) | 95.67 | 92.20 | 86.65 | 126.55 | 213.66 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of CARE RATINGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CARE RATINGS | ₹5,060.1 Cr | 2% | -0.1% | -10.3% | Stock Analytics | |
| CRISIL | ₹29,865.9 Cr | -1% | 1.4% | -25.4% | Stock Analytics | |
| ICRA | ₹5,129.1 Cr | 1.7% | -2.3% | -22.3% | Stock Analytics | |
CARE RATINGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CARE RATINGS | 2% |
-0.1% |
-10.3% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses
